Liigu edasi põhisisu juurde
Veterinary Medicines

PA-OLVAC +I+E Vaccino inattivato in emulsione iniettabile per tacchini

Authorised
  • Avian influenza virus A, H6N2, Inactivated
  • Avian influenza virus A, H9N2, Inactivated
  • Riemerella anatipestifer, serotype 3, Inactivated
  • Riemerella anatipestifer, serotype 1, Inactivated
  • Newcastle disease virus, Inactivated
  • Haemorrhagic enteritis virus, Inactivated

Ravimi identifitseerimine

Ravimi nimetus:
PA-OLVAC +I+E Vaccino inattivato in emulsione iniettabile per tacchini
PA-OLVAC +I+E Vaccino inattivato in emulsione iniettabile per tacchini
Toimeaine:
Loomaliigid:
  • kalkun
Manustamisviis:
  • Subkutaanne

Ravimiandmed

Toimeaine / Tugevus:
  • Turustatakse ainult English
  • Turustatakse ainult English
  • Turustatakse ainult English
    1.00
    billion colony forming units
    /
    0.50
    millilitre(s)
  • Turustatakse ainult English
    1.00
    billion colony forming units
    /
    0.50
    millilitre(s)
  • Turustatakse ainult English
    50.00
    50% Protective Dose
    /
    0.50
    millilitre(s)
  • Turustatakse ainult English
    1733.00
    enzyme-linked immunosorbent assay unit
    /
    0.50
    millilitre(s)
Ravimvorm:
  • Süsteemulsioon
Withdrawal period by route of administration:
  • Subcutaneous use
    • kalkun
      • liha ja söödavad koed
        0
        day
Veterinaarravimite anatoomilis-terapeutilise keemilise klassifikatsiooni (ATCvet) kohane kood:
  • QI01CL01
Müügiloa staatus:
  • Valid
Authorised in:
See teave selle ravimi kohta puudub.
Pakendi kirjeldus:

Lisateave

Entitlement type:
Müügiloa hoidja:
  • Fatro S.p.A.
Marketing authorisation date:
Partii vabastamise tootmiskohad:
  • Fatro S.p.A.
Vastutav asutus:
  • MdS
Authorisation number:
See teave selle ravimi kohta puudub.
Müügiloa staatuse muutmise kuupäev:

Dokumendid

Combined File of all Documents

Seda dokumenti selles keeles ei eksisteeri (eesti). Selle leiate allpool teises keeles.
Italian (PDF)
Avaldatud: 3/06/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."